Cerabone® literature overview

advertisement
Cerabone® literature overview
Cerabone® - eine Spongiosa-Keramik bovinen Ursprungs
P. Seidel, E. Dingeldein
Materialwissenschaft und Werkstofftechnik Volume 35 Issue 4, Pages 208–212 Published Online: 1 Apr
2004
Characterization of porous hydroxyapatite (Endobon).
Hing KA, Best SM, Bonfield W.
J Mater Sci Mater Med. 1999 Mar;10(3):135-45.
Bone substitutes as carriers for transforming growth factor-beta(1) (TGF-beta(1)).
Gille J, Dorn B, Kekow J, Bruns J, Behrens P.
Int Orthop. 2002;26(4):203-6. Epub 2002 Apr 23.
A thorough physicochemical characterisation of 14 calcium phosphate-based bone substitution
materials (Cerabone®) in comparison to natural bone.
Tadic D, Epple M.
Biomaterials. 2004 Mar;25(6):987-94.
Injectable nanocrystalline hydroxyapatite paste & solid hydroxyapatite ceramic (Cerabone®) for bone
substitution: in vivo analysis of biocompatibility and vascularization.
Laschke MW, Witt K, Pohlemann T, Menger MD.
J Biomed Mater Res B Appl Biomater. 2007 Aug;82(2):494-505
Biomechanical assessment of bone ingrowth in porous hydroxyapatite.
Hing KA, Best SM, Tanner KE, Bonfield W, Revell PA.
J Mater Sci Mater Med. 1997 Dec;8(12):731-6.
Evaluation of a novel nanocrystalline hydroxyapatite paste and a solid hydroxyapatite ceramic
(Cerabone®) for the treatment of critical size bone defects (CSD) in rabbits.
Huber FX, Berger I, McArthur N, Huber C, Kock HP, Hillmeier J, Meeder PJ.
J Mater Sci Mater Med. 2008 Jan;19(1):33-8. Epub 2007 Jun 14.
Mediation of bone ingrowth in porous hydroxyapatite (Cerabone®) bone graft substitutes.
Hing KA, Best SM, Tanner KE, Bonfield W, Revell PA.
J Biomed Mater Res A. 2004 Jan 1;68(1):187-200.
Madreporic hydroxyapatite granulates for filling bone defects
Müller-Mai C, Voigt C, Hering A, Rahmanzadeh R, Gross U.
Unfallchirurg. 2001 Mar;104(3):221-9
Various evaluation techniques of newly formed bone in porous hydroxyapatite Endobon loaded with
human bone marrow cells implanted in an extra-osseous site.
Bareille R, Lafage-Proust MH, Faucheux C, Laroche N, Wenz R, Dard M, Amédée J.
Biomaterials. 2000 Jul;21(13):1345-52.
Defect reconstruction using demineralized bone matrix. Experimental studies on piglets
Schnettler R, Dingeldein E, Herr G.
Orthopade. 1998 Feb;27(2):80-8.
Ectopic bone formation with the help of growth factor bFGF.
Wiltfang J, Merten HA, Wiltfang J.
J Craniomaxillofac Surg. 1996 Oct;24(5):300-4.
Tissue reaction and material characteristics of four bone substitutes.
Jensen SS, Aaboe M, Pinholt EM, Hjørting-Hansen E, Melsen F, Ruyter IE.
Int J Oral Maxillofac Implants. 1996 Jan-Feb;11(1):55-66.
Bone ingrowth in bFGF-coated hydroxyapatite ceramic Cerabone® implants.
Schnettler R, Alt V, Dingeldein E, Pfefferle HJ, Kilian O, Meyer C, Heiss C, Wenisch S.
Biomaterials. 2003 Nov;24(25):4603-8.
Void filling of tibia compression fracture zones using a novel resorbable nanocrystalline hydroxyapatite
paste in combination with a hydroxyapatite ceramic (Cerabone®) core: first clinical results.
Huber FX, McArthur N, Hillmeier J, Kock HJ, Baier M, Diwo M, Berger I, Meeder PJ.
Arch Orthop Trauma Surg. 2006 Oct;126(8):533-40. Epub 2006 Jul 12.
Treatment of dorsally displaced distal radius fractures with a double dorsal plate: a study of 12 patients
Fernandez Baca F, Benrahho J.
Chir Main. 2006 Feb;25(1):27-32.
Biocompatibility testing of different sterilised or disinfected allogenous bone grafts in comparison to the
gold standard of autologous bone grafts--an "in vitro" analysis of immunomodulation
Endres S, Kratz M, Heinz M, Herzberger C, Reichel S, von Garrel T, Gotzen L, Wilke A.
Z Orthop Ihre Grenzgeb. 2005 Nov-Dec;143(6):660-8.
Arthroscopic management of tibial plateau fractures
Attmanspacher W, Dittrich V, Staiger M, Stedtfeld HW.
Zentralbl Chir. 2002 Oct;127(10):828-36.
Long-term outcomes after using porous hydroxyapatite ceramics (Endobon) for surgical management of
fractures of the head of the tibia
Briem D, Linhart W, Lehmann W, Meenen NM, Rueger JM.
Unfallchirurg. 2002 Feb;105(2):128-33.
Osseous integration of hydroxyapatite (Endobon) grafts in metaphyseal bone defects of the proximal
tibia (CT-study).
Khodadadyan-Klostermann C, Liebig T, Melcher I, Raschke M, Haas NP.
Acta Chir Orthop Traumatol Cech. 2002;69(1):16-21.
Evaluation of hydroxyapatite implants (Endobon) in vertebral bodies and extremities by contrastenhanced magnetic resonance imaging.
Grimm J, Mueller-Huelsbeck S, Mueller M, Egbers HJ, Brinkmann G, Heller M.
Arch Orthop Trauma Surg. 2001;121(3):158-61.
Osseous integration of bovine hydroxyapatite ceramic Cerabone® in metaphyseal bone defects of the
distal radius.
Werber KD, Brauer RB, Weiss W, Becker K.
J Hand Surg [Am]. 2000 Sep;25(5):833-41.
Metaphyseal defect substitute: hydroxylapatite ceramic Endobon. Results of a 3 to 4 year follow up
Helber MU, Ulrich C.
Unfallchirurg. 2000 Sep;103(9):749-53.
Fractures of the distal forearm. Which therapy is indicated when?
Brug E, Joosten U, Püllen M.
Orthopade. 2000 Apr;29(4):318-26.
Reactions and complications after the implantation of Endobon including morphological examination of
explants.
Gierse H, Donath K.
Arch Orthop Trauma Surg. 1999;119(5-6):349-55.
Hydroxyapatite ceramics Endobon in clinical application. Histological findings in 23 patients
Liebendörfer A, Tröster S.
Unfallchirurgie. 1997 Apr;23(2):60-8.
Endobon® as a bone substitute in spine surgery. Preliminary study in 11 patients
P. Kehr, F. Gosset
European Journal of Orthopaedic Surgery & Traumatology Volume 10, Number 4 / Dezember 2000,
217-221
SPONGY HYDROXYAPATITE Endobon IN HAND SURGERY – A FIVE YEAR FOLLOW-UP
W. BAER, P. SCHALLER and H. D. CARL
The Journal of Hand Surgery: Journal of the British Society for Surgery of the Hand Volume 27, Issue 1,
February 2002, Pages 101-103
Evaluation of a novel nanocrystalline hydroxyapatite paste and a solid hydroxyapatite ceramic for the
treatment of critical size bone defects (CSD) in rabbits Huber FX, Berger I, McArthur N, Huber C, Kock
HP, Hillmeier J, Meeder PJ. J Mater Sci Mater Med. 2007 Jun 14
Injectable nanocrystalline hydroxyapatite paste for bone substitution: in vivo analysis of biocompatibility
and vascularization Laschke MW, Witt K, Pohlemann T, Menger MD. J Biomed Mater Res B Appl
Biomater. 2007 Aug;82(2):494-505
Void filling of tibia compression fracture zones using a novel resorbable nanocrystalline hydroxyapatite
paste in combination with a hydroxyapatite ceramic core: first clinical results Huber FX, McArthur N,
Hillmeier J, Kock HJ, Baier M, Diwo M, Berger I, Meeder PJ. Arch Orthop Trauma Surg. 2006
Oct;126(8):533-40
Treatment of dorsally displaced distal radius fractures with a double dorsal plate: a study of 12 patients
Fernandez Baca F, Benrahho J. Chir Main. 2006 Feb;25(1):27-32. French.
Biocompatibility testing of different sterilised or disinfected allogenous bone grafts in comparison to the
gold standard of autologous bone grafts--an "in vitro" analysis of immunomodulation
Endres S, Kratz M, Heinz M, Herzberger C, Reichel S, von Garrel T, Gotzen L, Wilke A. Z Orthop Ihre
Grenzgeb. 2005 Nov-Dec;143(6):660-8. German.
Biomechanical assessment of bone ingrowth in porous hydroxyapatite Hing KA, Best SM, Tanner KE,
Bonfield W, Revell PA. J Mater Sci Mater Med. 1997 Dec;8(12):731-6.
Characterization of porous hydroxyapatite Hing KA, Best SM, Bonfield W J Mater Sci Mater Med. 1999
Mar;10(3):135-45.
Mechanical failure of porous hydroxyapatite ceramics 7.5 years after implantation in the proximal tibial
Linhart W, Briem D, Amling M, Rueger JM, Windolf J. Unfallchirurg. 2004 Feb;107(2):154-7. German.
Mediation of bone ingrowth in porous hydroxyapatite bone graft substitutes Hing KA, Best SM, Tanner
KE, Bonfield W, Revell PA. J Biomed Mater Res A. 2004 Jan 1;68(1):187-200.
Arthroscopic management of tibial plateau fractures Attmanspacher W, Dittrich V, Staiger M, Stedtfeld
HW. Zentralbl Chir. 2002 Oct;127(10):828-36. German.
Bone substitutes as carriers for transforming growth factor-beta(1) (TGF-beta(1)) Gille J, Dorn B, Kekow
J, Bruns J, Behrens P. Int Orthop. 2002;26(4):203-6. Epub 2002 Apr 23.
Long-term outcomes after using porous hydroxyapatite ceramics (Endobon) for surgical management of
fractures of the head of the tibia Briem D, Linhart W, Lehmann W, Meenen NM, Rueger JM.
Unfallchirurg. 2002 Feb;105(2):128-33. German.
Osseous integration of hydroxyapatite grafts in metaphyseal bone defects of the proximal tibia (CTstudy) Khodadadyan-Klostermann C, Liebig T, Melcher I, Raschke M, Haas NP. Acta Chir Orthop
Traumatol Cech. 2002;69(1):16-21.
Madreporic hydroxyapatite granulates for filling bone defects Müller-Mai C, Voigt C, Hering A,
Rahmanzadeh R, Gross U. Unfallchirurg. 2001 Mar;104(3):221-9. German.
Evaluation of hydroxyapatite implants in vertebral bodies and extremities by contrast-enhanced
magnetic resonance imaging Grimm J, Mueller-Huelsbeck S, Mueller M, Egbers HJ, Brinkmann G,
Heller M. Arch Orthop Trauma Surg. 2001;121(3):158-61.
Osseous integration of bovine hydroxyapatite ceramic in metaphyseal bone defects of the distal radius
Werber KD, Brauer RB, Weiss W, Becker K. J Hand Surg [Am]. 2000 Sep;25(5):833-41.
Metaphyseal defect substitute: hydroxylapatite ceramic. Results of a 3 to 4 year follow up Helber MU,
Ulrich C. Unfallchirurg. 2000 Sep;103(9):749-53. German
Fractures of the distal forearm. Which therapy is indicated when? Brug E, Joosten U, Püllen M.
Orthopade. 2000 Apr;29(4):318-26. German.
Various evaluation techniques of newly formed bone in porous hydroxyapatite loaded with human bone
marrow cells implanted in an extra-osseous site Bareille R, Lafage-Proust MH, Faucheux C, Laroche N,
Wenz R, Dard M, Amédée J. Biomaterials. 2000 Jul;21(13):1345-52.
Reactions and complications after the implantation of Endobon including morphological examination of
explants Gierse H, Donath K. Arch Orthop Trauma Surg. 1999;119(5-6):349-55.
Defect reconstruction using demineralized bone matrix. Experimental studies on piglets Schnettler R,
Dingeldein E, Herr G. Orthopade. 1998 Feb;27(2):80-8. German.
Hydroxyapatite ceramics in clinical application. Histological findings in 23 patients Liebendörfer A,
Tröster S. Unfallchirurgie. 1997 Apr;23(2):60-8. German.
Ectopic bone formation with the help of growth factor bFGF Wiltfang J, Merten HA, Wiltfang J. J
Craniomaxillofac Surg. 1996 Oct;24(5):300-4.
Tissue reaction and material characteristics of four bone substitutes Jensen SS, Aaboe M, Pinholt EM,
Hjørting-Hansen E, Melsen F, Ruyter IE. Int J Oral Maxillofac Implants. 1996 Jan-Feb;11(1):55-66.
Download